Demant A/S: Transactions with Demant shares by Board of Directors and Executive Board and closely related parties

28.2.2024 12:16:31 CET | Demant A/S | Other information disclosed according to the rules of the Exchange

Company announcementno 2024-05

28 February 2024

Transactions with Demant shares by Board of Directors and Executive Board and closely related parties

Notification on transactions pursuant to article 19 of the Market Abuse Regulation:

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Niels Jacobsen
2.	Reason for the notification
a)	Position/status	Vice Chair of the Board of Directors
b)	Initial notification/amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Demant A/S
b)	LEI	213800RM6L9LN78BVA56
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument   Identication code	Shares     DK0060738599
b)	Nature of the transaction	Sale
c)	Price(s) and volume(s)	Price                  Volume DKK 366.62         100,000 shares   Minimum price  DKK 364.55 Maximum price DKK 369.40
d)	Aggregated information: - Aggregated volume - Price	100,000 shares DKK 366.62
e)	Date of the transaction	27 February 2024
f)	Place of the transaction	Nasdaq Copenhagen A/S

Further information: Mathias Holten Møller, Head of Investor Relations Peter Pudselykke, Investor Relations Officer Henrik Axel Lynge Buchter, Manager of External Communications   Phone [phone] www.demant.com

Contacts

• Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, [phone], [e-mail]

About Demant A/S

Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.

Attachments

• 2024-05 Board of Directors and Executive Board and closely related parties transactions with Demant shares.pdf

© Ritzau Denmark, source Ritzau English Regulatory Releases